Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

Brian H Ramnaraign, MD

Cancer Specialist (Oncologist), Hematology and Oncology Specialist

Photo of Brian H Ramnaraign
MyUFHealth

Research at a glance

Top areas of exploration

  • Antineoplastic Combined Chemotherapy Protocols , 3 publications
  • Antineoplastic Agents , 2 publications
  • Adenocarcinoma , 2 publications
  • Decision Support Techniques , 1 publications

Research activity

23 publications

74 citations

Why is this important?

Focus

Google Scholar: https://scholar.google.com/citations?user=OBsb4P4AAAAJ&hl=en

Active clinical trials

My publications

23 publications

2024

Clinical Presentation and Targeted Interventions in Urachal Adenocarcinoma: A Single-Institution Case Series and Review of Emerging Therapies

Clinical Genitourinary Cancer

Publisher's site

2023

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Future Oncology

PubMed • Publisher's site

2023

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.

Oncotarget

PubMed • Publisher's site

2023

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis.

Journal of hepatocellular carcinoma

PubMed • Publisher's site

2023

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.

Oncotarget

PubMed • Publisher's site